www.nature.com/articles/s41...
rdcu.be/CUdZDsYKESpa
This new Review covers the therapeutic landscape for inhibitors of enzymes such as LSD1 (KDM1A), which are in clinical trials for cancer and other diseases
www.nature.com/articles/s41...
rdcu.be/CUdZDsYKESpa
This new Review covers the therapeutic landscape for inhibitors of enzymes such as LSD1 (KDM1A), which are in clinical trials for cancer and other diseases
onlineprogram.hematology.org/paper-detail...
onlineprogram.hematology.org/paper-detail...
🔗 Source: https://pubmed.ncbi.nlm.nih.gov/42933642/
🔗 Source: https://pubmed.ncbi.nlm.nih.gov/42933642/
PRMT5, EZH2, LSD1, CBP/P300, heterochromatin, BRD4
Happy to contribute a bit (Mechano-epigenetics; Aneurysm) to this review by my PhD supervisor😁
#VasPharma 2026
www.sciencedirect.com/science/arti...
PRMT5, EZH2, LSD1, CBP/P300, heterochromatin, BRD4
Happy to contribute a bit (Mechano-epigenetics; Aneurysm) to this review by my PhD supervisor😁
#VasPharma 2026
www.sciencedirect.com/science/arti...
Zhang et al. demonstrate LSD1 as a key regulator of DNA damage-induced senescence and organ aging and highlights it as a promising therapeutic target.
Zhang et al. demonstrate LSD1 as a key regulator of DNA damage-induced senescence and organ aging and highlights it as a promising therapeutic target.
1001 could reduce LSD1 expression, and treatment with senolytic drugs (Dasatinib and Quercetin) could ameliorate cellular senescence and organ aging.
1001 could reduce LSD1 expression, and treatment with senolytic drugs (Dasatinib and Quercetin) could ameliorate cellular senescence and organ aging.
Working with a key intermediate from the Harvard Liau Group, we achieved high-throughput chiral separation using CHIRALPAK® IK—100 mg/hr on a 4.6 mm column.
🔗 chiraltech.com/wp-content/u...
#ChiralSeparation #LSD1 #CancerResearch #Harvard #HPLC #DrugDiscovery
Working with a key intermediate from the Harvard Liau Group, we achieved high-throughput chiral separation using CHIRALPAK® IK—100 mg/hr on a 4.6 mm column.
🔗 chiraltech.com/wp-content/u...
#ChiralSeparation #LSD1 #CancerResearch #Harvard #HPLC #DrugDiscovery
🗓️ 05/06/26 - 12:30
👨🔬 Dr. José Manuel Pérez-Pérez
📰 Functional analysis of plant LSD1/KDM1A proteins
💻 Zoom: bit.ly/3Ph5CIP (🔐627464)
🏛️ Instituto de Bioingeniería (Universidad Miguel Hernández de Elche)
#Research #PlantScience #PlantBiology
🗓️ 05/06/26 - 12:30
👨🔬 Dr. José Manuel Pérez-Pérez
📰 Functional analysis of plant LSD1/KDM1A proteins
💻 Zoom: bit.ly/3Ph5CIP (🔐627464)
🏛️ Instituto de Bioingeniería (Universidad Miguel Hernández de Elche)
#Research #PlantScience #PlantBiology
Tobias B. Huber & team show LSD1 regulates kidney development, and its dysfunction disrupts key kidney cells, leading to cyst formation in mouse and organoid models: doi.org/10.1172/jci....
Tobias B. Huber & team show LSD1 regulates kidney development, and its dysfunction disrupts key kidney cells, leading to cyst formation in mouse and organoid models: doi.org/10.1172/jci....
Altered chromatin accessibility and nucleosome positioning landscape upon HDAC and LSD1 inhibition in cancer cell
https://www.biorxiv.org/content/10.64898/2026.04.08.717275v1
Altered chromatin accessibility and nucleosome positioning landscape upon HDAC and LSD1 inhibition in cancer cell
https://www.biorxiv.org/content/10.64898/2026.04.08.717275v1
Altered chromatin accessibility and nucleosome positioning landscape upon HDAC and LSD1 inhibition in cancer cell
https://www.biorxiv.org/content/10.64898/2026.04.08.717275v1
Altered chromatin accessibility and nucleosome positioning landscape upon HDAC and LSD1 inhibition in cancer cell
https://www.biorxiv.org/content/10.64898/2026.04.08.717275v1